Background {#Sec1}
==========

Leishmaniasis, an infection caused by obligate intramacrophage protozoa transmitted predominantly by the bite of an infected phlebotomine female sandfly is endemic throughout tropical and subtropical regions \[[@CR1]\]. Cutaneous leishmaniasis (CL), which is characterised by ulcerative lesions on the skin (localised CL) and nonulcerative nodules (diffuse CL) is endemic in 88 countries with an estimated 1.5--2 million new cases every year and a total of 12 million cases worldwide \[[@CR2], [@CR3]\]. There has been a recent re-emergence of this disease in endemic countries and an increase in imported cases in non-endemic countries where travelers, workers, expatriates, immigrants, and military force personnel have been the main victims \[[@CR2], [@CR4]--[@CR6]\]. CL is amongst the top ten diseases in tourists returning from tropical countries with skin problems \[[@CR2], [@CR7]\]. Old World CL (OWCL), prevalent in southern Europe, Mediterranean basin, Africa and the Middle-East is caused primarily by *Leishmania major*, *L. tropica* and *L. aethiopica* \[[@CR4], [@CR8]\], although CL cases due to *L. donovani* and *L. infantum* strains have also been reported \[[@CR9], [@CR10]\].

Diagnosis of CL traditionally includes microscopic examination of Giemsa-stained biopsy smears or tissue aspirates, histopathological examination, and *in vitro* cultivation. These methods however, in spite of their high specificity, are poorly sensitive and their sensitivity largely depends on the sampling procedure, parasite distribution and ad hoc expertise. Serological assays such as Enzyme-linked Immunosorbent Assay (ELISA), indirect fluorescence antibody test (IFAT) and western blot (WB) are preferred for the diagnosis of visceral leishmaniasis (VL) rather than CL due to the low titre of circulating antibodies against the parasite and cross-reactivity with other antigens (e.g. *Trypanosoma cruzi*) \[[@CR11]\].

Molecular diagnostic methods such as PCR are the current preferred method of diagnosis due to their high specificity, sensitivity (98--100 %) and speed \[[@CR12], [@CR13]\]. Identification of the parasite at the species level is often crucial for epidemiological studies, transmission control measures, disease prognosis and choice of treatment \[[@CR14], [@CR15]\]. Before the advent of PCR protocols, the species of *Leishmania* was determined by enzyme-based assays such as Multi Locus Enzyme Typing (MLET) which were both time-consuming and labour-intensive. Several PCR-based techniques have been developed for species identification that require post-PCR processing such as electrophoretic analysis, PCR-restriction fragment length polymorphism (PCR-RFLP), PCR-ELISA and sequencing \[[@CR16]--[@CR19]\].

Real-time PCR not only allows the accurate detection and quantification of specific DNA in real time but also allows species identification without the requirement of post-PCR processing. Samples can be processed in less than one hour and the technique has been reported to rapidly differentiate single nucleotide mutations within a target DNA sequence \[[@CR20]\]. To date, real-time PCR using SYBR green dye I has been reported several times for species discrimination \[[@CR14], [@CR21]--[@CR24]\]. However, this method detects all amplified double-stranded DNA, including non-specific reaction products and can thereby generate false positive signals \[[@CR25]\]. Recently, probe-based real-time PCR using Fluorescence Resonance Energy Transfer (FRET) identifies and distinguishes between New World tegumentary *Leishmania* species in clinical samples based on melting curve profiles with high specificity \[[@CR26]\] thereby eliminating false positives.

Different PCR primers have been developed or applied for the detection and/or identification of *Leishmania* species \[[@CR27]\]. One gene of interest, the *cpb* gene, encodes for cathepsin L-like cysteine proteinase B (*cpb*), a major antigen of *Leishmania* parasites and is conserved among the *Leishmania* species \[[@CR28]\]. Its polymorphic and multi-copy nature presents an excellent opportunity for the development of species specific and sensitive primers \[[@CR29]\]. Currently, separate primer sets targeting the *cpb* gene are needed to identify the OWCL species using conventional PCR, therefore requiring post-PCR processing \[[@CR27]\] and this technique has demonstrated a lack of sensitivity in clinical samples \[[@CR30]\].

In the present study, we describe a real-time PCR assay using FRET technology that is based on the amplification of the cathepsin L-like cysteine protease B (*cpb*) gene, to differentiate the main OWCL species: *L. major, L. tropica*, and *L. aethiopica*, in cultured parasite isolates and biopsy specimens. Currently, there are no published data on real-time PCR using FRET technology to differentiate between these OWCL species. This FRET-based real-time PCR assay requires specific hybridization between the probe and its target to generate a fluorescent signal thereby addressing the limitations of the SYBR green technology and providing a rapid, single step, reliable method of species identification for OWCL.

Methods {#Sec2}
=======

Ethics statement {#Sec3}
----------------

Samples were obtained from multiple reference laboratories including the Canadian National Reference Centre for Parasitology/J.D. MacLean Centre for Tropical Diseases at McGill University (Montreal, QC), Centre Hospitalier Régional Universitaire of Montpellier and University Montpellier I (Montpellier, France) and Walter Reed Army Institute of Research (Silver Spring, Maryland) and were considered exempt. All samples used in this study were anonymized.

*Leishmania* reference strain samples {#Sec4}
-------------------------------------

DNA from *L. major*, *L. tropica*, and *L. aethiopica* promastigotes and cryopreserved promastigote cultures of various *Leishmania* reference strains were provided by the International Biological Resources Center for Leishmania, affiliated to the French National Reference Center for Leishmanioses, University Hospital Center of Montpellier, France. Additional DNA from *L. aethiopica* strains (promastigote stage) was provided by the Walter Reed Army Institute of Research, USA. An overview of all strains used is presented in Table [1](#Tab1){ref-type="table"}.Table 1Overview of *Leishmania* strains usedSpeciesStrainParasite cultureBiopsyProvider*L. aethiopica*MHOM/ET/96/WR2315^a^NoNoWRAIRMHOM/SD/99/WR2885^a^NoNoWRAIRMHOM/PH/2010/WR2970^a^NoNoWRAIRMHOM/ET/83/130-83^c^NoNoFNRCLMHOM/ET/90/DISKO^c^NoNoFNRCLMHOM/ET/70/L96^c^NoNoFNRCLMHOM/ET/81/1091-81^c^NoNoFNRCLMPRV/ET/71/L111^c^NoNoFNRCL*L. tropica*MHOM/IQ/65/L75YesNoFNRCLMHOM/SU/74/K27YesNoFNRCLI000/IL/98/LRC-L757YesNoFNRCLMHOM/AF/06/NRCP2559^b^YesYesNRCPMHOM/AF/05/NRCP358^b^YesYesNRCPMHOM/SU/66/III^c^NoNoFNRCLMHOM/KE/91/EB135^c^NoNoFNRCLMHOM/MA/95/LEM3015^c^NoNoFNRCLMHOM/IR/2000/LEM4036^c^NoNoFNRCL*L. major*MHOM/IL/81/FriedlinYesNoNRCPMHOM/DZ/05/NRCP684^b^YesYesNRCPMHOM/BF/06/NRCP2082^b^YesYesNRCPMHOM/BF/06/NRCP2204^b^YesYesNRCPMHOM/TN/06/NRCP248^b^YesYesNRCPMHOM/BZ/05/NRCP2620^b^YesYesNRCPMRHO/SU/59/P-STRAIN^c^NoNoFNRCLMHOM/SU/73/29-ASKH^c^NoNoFNRCLMHOM/IL/83/IL24^c^NoNoFNRCLMTAT/KE/00/T4^c^NoNoFNRCLMHOM/DZ/89/LIPA228^c^NoNoFNRCL*L. chagasi*MHOM/BR/74/M2682YesNoFNRCL*L. infantum*MHOM/TN/80/IPT1YesNoFNRCLMHOM/MA/67/ITMAP263YesNoFNRCL*L. donovani*MHOM/IN/80/DD8YesNoFNRCLMHOM/KE/55/LRC-L53YesNoFNRCLMHOM/IQ/77/BUMM3YesNoFNRCLMHOM/YE/86/LEM934YesNoFNRCLMHOM/SD/90/2828YesNoFNRCL*L. mexicana*MHOM/BZ/82/BEL21YesNoFNRCLMNYC/BZ/62/M379YesNoFNRCL*L. panamensis*MHOM/PA/71/LS94YesNoFNRCL*L. guyanensis*MHOM/GF/79/LEM85YesNoFNRCL*L. peruviana*MHOM/PE//84/UN56YesNoFNRCLMHOM/PE/84/LC39YesNoFNRCL*L. braziliensis*MHOM/PE/90/ACYesNoFNRCLMHOM/CO/90/UA482YesNoFNRCLMHOM/BR/75/M2904YesNoFNRCLMHOM/BR/75/M2903bYesNoFNRCL*WRAIR* Walter Reed Army of Institute of Research, USA*NRCP* National Reference Centre for Parasitology, Canada*FNRCL* French National Reference Center for Leishmanioses, France^a^DNA samples were provided by WRAIR^b^DNA was extracted directly from patient biopsies^c^DNA samples were provided by FNRCLFor all other strains, DNA was extracted directly from parasite

Cutaneous lesion specimens {#Sec5}
--------------------------

Cutaneous biopsy specimens which were sent to the National Reference Center for Parasitology between 2005 and 2006 for *Leishmania* testing, and were found to be positive in culture and by conventional PCR \[[@CR31]\], were used to validate the real-time PCR assay. These biopsy culture isolates were also species typed by isoenzyme electrophoresis at the Walter Reed Army Institute of Research, USA. An overview of the specimens used is presented in Table [1](#Tab1){ref-type="table"}.

Cell culture and DNA extraction {#Sec6}
-------------------------------

Cryopreserved promastigotes and patient skin biopsies suspected of being positive for *Leishmania* were cultivated *in vitro* at 27 °C in RPMI 1640 medium (Wisent, St-Bruno, QC) supplemented with 20 % fetal bovine serum, non-essential amino acids (Wisent, St-Bruno, QC), MEM amino acids (Wisent), 1 mM sodium pyruvate, 2 mg/ml dextrose, 2 mM L-glutamine, 100 u/ml penicillin/streptomycin, and 25 mM HEPES. A set of control DNA standards from cultured promastigotes was prepared to determine the sensitivity of the real-time PCR. Promastigotes of *L. major*, *L. tropica* and *L. aethiopica* were suspended in PBS and uninfected human blood, counted in a Neubauer hemacytometer (Hausser Scientific, Horsham, PA) and diluted at a concentration of 10^6^ parasites/200 μl. Ten-fold dilutions were made to 10^−2^ parasites/200 μl. DNA was extracted from the promastigote dilutions and directly from patient skin biopsies using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. Following centrifugation and washing steps, DNA was eluted from the spin columns in 200 μl elution buffer and stored at -20 °C until use. Similarly, non-leishmanial protozoan DNA was extracted from blood specimen positive for *Plasmodium* species*, Trypanosoma cruzi* and *Trypanosoma brucei*, and from parasite cultures of *Toxoplasma gondii* RH strain (courtesy of Gary E. Ward, University of Vermont), *Giardia lamblia* ATCC® 30957 (courtesy of Gaetan Faubert, Institute of Parasitology, Quebec), *Cryptosporidium parvum* Iowa strain (courtesy of Michael Arrowood, Center for Disease Control) and *Entamoeba histolytica* ATCC® 30015.

Primer and probe design {#Sec7}
-----------------------

Consensus primers and probes, designed by TIBMol Biological (New Jersey, USA), were based on the alignment of *cpb* sequences for *L. major* (GenBank: AJ512654), *L. tropica* (GenBank: DQ286773) and *L. aethiopica* (GenBank: DQ071678). Alignment was done using ClustalW2 (v2.0.12, European Bioinformatics Institute, [http://www.ebi.ac.uk](http://www.ebi.ac.uk/)). By comparing the *cpb* sequences of *L. major*, *L. tropica* and *L. aethiopica*, oligonucleotides were designed such that the FRET hybridization assay could selectively amplify DNA from each species, but allow for differences on melting curve temperature (Tm) analysis. The *cpb* sequence was almost identical for *L. tropica* and *L. aethiopica* with 96 % similarity. *L. major cpb* sequence shared 92 % similarity with that of *L. tropica* and 91 % similarity with that of *L. aethiopica*. A single primer and probe set was designed to amplify specimens from the OWCL species (Fig. [1a](#Fig1){ref-type="fig"}). Probes were designed to be specific for *L. tropica* and identify a single base-pair mismatch in *L. major* and two base-pair mismatches in *L. aethiopica*. The forward primer contains one wobble base to identify adenosine in the *cpb* gene of *L. aethiopica* and *L. major* as well as guanine in *L. tropica cpb* gene. Primers and probes (Table [2](#Tab2){ref-type="table"}) were aligned with OWCL species and with those causing visceral and mucocutaneous forms (Fig. [1b](#Fig1){ref-type="fig"}).Fig. 1**a** Primer and fluorescence probe positions selected for FRET-based real-time PCR of *Leishmania* cathepsin L-like cysteine protease B gene. Sequences of forward (cpb F) and reverse (cpb R) primers were aligned with the corresponding target sequences. Forward primer harbors one wobble base (R = A/G). FRET hybridization probes (cpb sensor 2 and cpb anchor 2) were both designed antisense for detection of parasite. Sensor FRET hybridization probe was designed to be specific for cathepsin L-like cysteine protease B gene of *L. tropica* (GenBank Accession number: DQ286773) with one nucleotide mismatch difference from that of *L. major* (GenBank Accession number: AJ512654) and two nucleotide mismatch differences from that of *L. aethiopica* (GenBank Accession number: DQ071678). **b** Alignment of the OWCL species and species causing visceral and mucocutaneous leishmaniasis. Sequences are colour-coded by percentage identityTable 2Primers and probes for the simultaneous detection and identification of OWCL speciesNameSequence (5' ➔ 3')FunctionPrimerscpb FCGGCARCATCGAGTCGCScpb RGGTCCCGTTCATGTTTCGASFluorescent-labeled probescpb sensor 2TCGAACGCCTGCAGCATC---FLAScpb anchor 2LC640-GCCCGCCGCCGCAA---PHAS*S* sense sequence, *AS* antisense sequence

FRET-based real-time PCR {#Sec8}
------------------------

Real-time PCR reactions were performed using the Light Cycler Fast Start DNA Master HybProbe kit (Roche, Mannheim, Germany) and contained 2 μl of 10× Master Mix, 5 mM final MgCl~2~ concentration, 0.2 μM of each probe, 0.5 μM of each primer, and 2 μl of template DNA in a final volume of 20 μl. Real-time PCR cycling was performed on the Light Cycler 1.5 (Roche) with amplification at 95 °C for 10 min followed by 40 cycles of 95 °C for 5 s, 53 °C for 8 s, and 72 °C for 9 s, with single fluorescence acquisition at the end of each annealing step. Amplification was followed by a melting program of 95 °C for 20 s, 40 °C for 20 s, and a final increase to 85 °C at the rate of 0.2 °C/s with continuous fluorescence acquisition. To ensure the reproducibility of the assay, DNA from reference strains (*L. major* MHOM/IL/81/Friedlin, *L. tropica* MHOM/IQ/65/L75, and *L. aethiopica* MHOM/ET/96/WR2315) were included as positive controls in each run. An uninfected human DNA sample and a water sample were included as negative template and non-template controls respectively in each run.

Direct sequencing and analysis {#Sec9}
------------------------------

In order to ensure primer specificity and for validation, PCR products amplified from both promastigote and cutaneous biopsy DNA were subjected to agarose gel electrophoresis containing ethidium bromide and visualized under ultraviolet light. The band of interest was purified with QIAquick Gel Extraction Kit (QIAGEN, Hilden, Germany) and sent for direct Sanger sequencing to the McGill University and Génome Québec Innovation Centre, Montreal, Canada. Sequencing of samples was performed with cpb F and cpb R primers. The quality of the sequences were evaluated and edited with Geneious software (version 9.0.4 -- restricted access) and the *Leishmania* species were identified by *BLASTm* accessible at *Genbank* (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>). The sequences were subsequently aligned with the primers and probes using Jalview software (version 2.9.0b2 - restricted access).

Results {#Sec10}
=======

Species-specific FRET-based real-time PCR {#Sec11}
-----------------------------------------

Using the FRET hybridization approach, species-specific real-time PCRs were performed on 28 DNA samples isolated from promastigote cultures of *L. tropica*, *L. aethiopica* and *L. major* reference strains. A species-specific amplicon with cpb F and cpb R primers was visualized in all *L. tropica*, *L. aethiopica*, and *L. major* strains. Melting curve analysis was able to differentiate between the species. A single Tm at 55.2 ± 0.5 °C for *L. aethiopica* strains was distinguished from a single Tm at 57.4 ± 0.2 °C for *L. major* strains. A double curve with a melting peak at 66.6 ± 0.1 °C and a peak at either 48.1 ± 0.5 °C or 55.8 ± 0.6 °C was observed for all *L. tropica* strains (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Example of a species-specific FRET-based real-time PCR result. OWCL species were differentiated by melting curve analysis. Single peaks visualized in *L. aethiopica* (Tm = 55.2 ± 0.5 °C) strains were distinguished from those of *L. major* (Tm = 57.4 ± 0.2 °C) or *L. tropica* with the latter showing double peaks (Tm = 66.6 ± 0.1 °C and 48.1 ± 0.5 °C or 55.8 ± 0.6 °C)

The sensitivity of the real-time PCR was tested using serial dilutions of parasite DNA extracted from a known number of parasites. The *cpb* DNA of *L. major*, *L. tropica* and *L. aethiopica* could be detected at a level corresponding to 0.01 parasite per reaction volume of 20 μl. The detection limit was 10^−1^ parasite/200 μl of human blood, taking into account the amount of biological sample used in the reaction (2 μl of sample DNA) and the elution volume of the extracted DNA (200 ul).

Non-species-specific real-time PCR {#Sec12}
----------------------------------

The specificity of the technique was validated using DNA from 18 strains of *Leishmania* causing mucocutaneous and visceral leishmaniasis from both the Old and New World as well as DNA from other protozoan parasites (Table [3](#Tab3){ref-type="table"}). Non-specific low melting peak temperatures of 44.5 °C was observed for both *L. chagasi* and *L. infantum,* and 45.0 ± 0.7 °C for *L. donovani*. The primers cpb F and cpb R had no specificity for DNA from New World *Leishmania* species and non-leishmanial parasites (Table [3](#Tab3){ref-type="table"}).Table 3Melting curve temperatures obtained from FRET-based real-time PCR assaySpecies-specificSpeciesStrainPeakTm (°C)  *Leishmania aethiopica*MHOM/ET/96/WR2315Single54.5MHOM/SD/99/WR2885Single54.5MHOM/PH/2010/WR2970Single55.3MHOM/ET/83/130-83Single55.5MHOM/ET/90/DISKOSingle55.5MHOM/ET/70/L96Single55.5MHOM/ET/81/1091-81Single55.5MPRV/ET/71/L111Single55.5  *L. tropica*MHOM/IQ/65/L75Double55.3 \| 66.8MHOM/SU/74/K27Double47.5 \| 66.5I000/IL/98/LRC-L757Double55.5 \| 66.8MHOM/AF/06/NRCP2559Double47.3 \| 66.5MHOM/AF/05/NRCP358Double48.5 \| 66.5MHOM/SU/66/IIIDouble48.5 \| 66.5MHOM/KE/91/EB135Double56.5 \| 66.5MHOM/MA/95/LEM3015Double48.0 \| 66.5MHOM/IR/2000/LEM4036Double48.5 \| 66.5  *L. major*MHOM/IL/81/FriedlinSingle57.0MHOM/DZ/05/NRCP684Single57.3MHOM/BF/06/NRCP2082Single57.5MHOM/BF/06/NRCP2204Single57.3MHOM/TN/06/NRCP248Single57.3MHOM/BZ/05/NRCP2620Single57.3MRHO/SU/59/P-STRAINSingle57.3MHOM/SU/73/29-ASKHSingle57.5MHOM/IL/83/IL24Single57.5MTAT/KE/00/T4Single57.5MHOM/DZ/89/LIPA228Single57.5Non-species specific (causing visceral or mucocutaneous clinical manifestations)SpeciesStrainPeakTm (°C)  *L. chagasi*MHOM/BR/74/M2682Non-specific single44.5  *L. infantum*MHOM/TN/80/IPT1Non-specific single44.5MHOM/MA/67/ITMAP263Non-specific single44.5  *L. donovani*MHOM/IN/80/DD8Non-specific single45.8MHOM/KE/55/LRC-L53Non-specific single44.5MHOM/IQ/77/BUMM3Non-specific single44.5MHOM/YE/86/LEM934Non-specific single45.8MHOM/SD/90/2828Non-specific single44.5  *L. mexicana*MHOM/BZ/82/BEL21None-MNYC/BZ/62/M379None-  *L. panamensis*MHOM/PA/71/LS94None-  *L. guyanensis*MHOM/GF/79/LEM85None-  *L. peruviana*MHOM/PE/84/UN56None-MHOM/PE/84/LC39None-  *L. braziliensis*MHOM/PE/90/ACUndefined peak-MHOM/CO/90/UA482None-MHOM/BR/75/M2904None-MHOM/BR/75/M2903bNone-Other protozoaSpeciesStrainPeakTm (°C)  *Plasmodium falciparum*10-4881None-10-4830None-  *Plasmodium malariae*10-3066None-  *Plasmodium ovale*10-2848None-  *Plasmodium vivax*99-551None-  *Trypanosoma cruzi*10-4342None-10-3447None-08-3341None-08-2636None-08-2634None-  *Trypanosoma brucei*09-255None-08-3460None-00-659 (control)None-  *Toxoplasma gondii*RH strainNone-  *Entamoeba histolytica*ATCC® 30015None-  *Cryptosporidium parvum*Iowa strainNone-  *Giardia lamblia*ATCC® 30957None-

We tested the cross-reactivity of our assay by analysing 17 samples known to contain other parasites including *Plasmodium falciparum*, *P. ovale*, *P. malariae*, *P. vivax*, *Trypanosoma cruzi*, *Trypanosoma brucei*, *Toxoplasma gondii*, *Entamoeba histolytica*, *Cryptosporidium parvum* and *Giardia lamblia* along with the reference strains *L. major* MHOM/IL/81/Friedlin, *L. aethiopica* MHOM/ET/96/WR2315 and *L. tropica* MHOM/KE/91/EB135. Final concentrations ranging from 0.08 μg/mL to 6.4 μg/mL were used to assess the specificity of the real-time PCR. Cross-reactivity was ruled out since amplification was only observed in the three reference strains (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Cross-reactivity of OWCL FRET-based real-time PCR tested with other protozoa

FRET-based real-time PCR on biopsy samples {#Sec13}
------------------------------------------

We used the FRET hybridization assay on DNA extracted from seven patients found positive for *Leishmania* by conventional PCR amplification of the 120 bp region of kinetoplast DNA \[[@CR32]\]. By melting peak temperature comparison with the reference strains, five of these patients were identified as being infected with *L. major* and two with *L. tropica* (Table [1](#Tab1){ref-type="table"}). Species identification for these samples was confirmed by isoenzyme analysis at the Walter Reed Army Institute of Research, USA and further confirmed by Sanger sequencing.

Direct sequencing and analysis {#Sec14}
------------------------------

A distinct band of 154 bp was visualized for all *L. major*, *L. tropica* and *L. aethiopica* strains. Similarly, a band was also seen at 154 bp for all species within the *L. (L.) donovani* complex.

Sequence comparison with available data in the *Genbank* database confirmed the amplification of the *Leishmania cpb* gene in all seven DNA biopsy specimen. Specimen positive for *L. major* by FRET real-time PCR showed 100 % identity with several *L. major cpb* gene sequences including those found in isolates from Tunisia (Accession No. JN400175) and those positive for *L. tropica* showed 99--100 % identity with several *L. tropica cpb* gene sequences deposited at the GenBank database.

Discussion {#Sec15}
==========

We describe the development of a FRET-based real-time PCR using primers and probes targeting the *cpb* gene sequence to detect and identify the OWCL species (*L. major*, *L. tropica* and *L. aethiopica*) in a single step. This assay was able to produce unique, specific, and reproducible melting curves that could distinguish the three OWCL species (Fig. [2](#Fig2){ref-type="fig"}). The *cpb* sequence for each of the three species of interest has a single or double nucleotide difference from each other, allowing a difference of at least 2 °C between the Tm values, and enabling easy and reproducible distinction during melting curve analysis. The variation between strains within a single species is minor and did not interfere with the identification of any of the cutaneous strains tested. The Tms for all *L. major* and *L. aethiopica* strains showed standard deviations of only 0.2 and 0.5 °C, respectively.

*L. tropica* presented a unique bimodal peak with the second peak showing a consistent Tm. The first peak however showed greater Tm variation. It has been suggested that the first peak could indicate DNA fragments denaturing at lower temperatures such as primer-dimers and non-specific products which usually melt at a lower temperature than desired products \[[@CR33]\]. However, all *L. tropica* strains tested showed only one discrete band on the agarose gel. Sequencing results from all *L. tropica* strains showed internal sequence differences. In the past, phylogenetic analysis and Multilocus Enzyme Electrophoresis (MLEE) have revealed genetic diversity and a high degree of allelic heterozygosity within *L. tropica* isolates \[[@CR34], [@CR35]\]. These differences may reflect distinct lineages of each strain and may explain the variation in melting characteristics of the first peak. Thus, species differentiation by melting curve analysis can be based on more than a single peak and its associated Tm \[[@CR36]--[@CR38]\]. In our assay, the unique bimodal peak from a single amplicon can be used in the detection and differentiation of *L. tropica* species from other cutaneous species.

Melting curve peaks for visceral species of *L. chagasi*, *L. infantum* and *L. donovani* were visible at 44.8 ± 0.6 °C. Peaks at low melting point temperatures are usually indicative of either primer-dimers due to their small size or amplification of non-specific products. However, gel results for these species indicate the presence of the target band at 154 bp. Although, the presence of a band confirms the identity of the parasite at the genus level, real-time PCR using melting curve analysis would enable species identification. In this case, the presence of a low Tm could be used as a possible marker to differentiate between *Leishmania* (*L.*) *donovani* complex and *L. tropica* complex. However, a prospective study would be necessary to assess and validate this.

The Tm values for the control reference DNA were highly reproducible on repeated melting curve runs. The melt peaks obtained with our technique are specific for *Leishmania* species and DNA from other protozoa was not amplified. Other investigators, using melting curve techniques such as high resolution melt analysis, found non-specific amplicons with non-leishmanial DNA although these did not overlap with the *Leishmania* species \[[@CR39]\].

We also tested our FRET-based real-time PCR on seven patient biopsy samples received by the NRCP that were confirmed to be positive for CL by culture and conventional PCR, and were identified as *L. major* (five samples) and *L. tropica* (two samples) by the Walter Reed Army Institute of Research using isoenzyme electrophoresis. The five samples isoenzyme-typed as *L. major* showed Tm at 57.3 ± 0.1 °C and those typed as *L. tropica* showed double peaks at Tm 47.9 ± 0.9 and 66.5 °C, thus yielding Tms consistent with our previous results. This highlights the fact that our assay can be performed directly on patient samples without the need for isolation of parasites. We acknowledge that a small number of samples were used in this study. Ideally, this methodology could be further validated using a larger number of strains from a wide variety of sources and geographical areas. A future study conducted on a large sampling of clinical specimen would be necessary to validate this assay on patient DNA. Interestingly, one of the patients (MHOM/BZ/05/NRCP2620) positive for *L. major* in our real-time PCR assay as well in a blind panel for isoenzyme-typing by the Walter Reed Army Institute of Research, had demonstrated travel history to Belize. Given the above results, the presence of *L. major* in Belize comes as a surprise where this specie was not previously reported in this country. It is possible that the patient may have traveled to a *Leishmania major* endemic country prior to travel to Belize. However, rare cases of *L. major*-like strains have been reported and confirmed in New World countries \[[@CR40], [@CR41]\].

Species differentiation by real-time PCR is a highly effective tool in diagnostic laboratories that overcomes the drawbacks of conventional PCR. To date, most real-time PCR assays for cutaneous species differentiation have been developed using the SYBR Green method. Nevertheless, this method has failed to identify or differentiate between some species or requires separate PCRs for each species \[[@CR14], [@CR21], [@CR23], [@CR42], [@CR43]\]. Recently, real-time PCRs have been developed in conjunction with FRET-based melting curve analysis for species and genus identification \[[@CR44]--[@CR46]\]. To our knowledge, this FRET-based nested real-time PCR was used to identify New World tegumentary leishmaniasis species targeting the mannose phosphate isomerase gene and the 6-phosphogluconate dehydrogenase gene by melting curve analysis \[[@CR26]\]. Using this approach, results can be obtained within a short turnaround time and with relatively low costs.

Whole product melting curve analysis is recommended for species identification because it is more tolerant to small sequence differences that might result from intraspecific variation \[[@CR47]\]. For diagnostic purposes, a probe-based real-time PCR assay is the preferred method due to its enhanced specificity as well as ease of analysis of the melting curves for species detection and differentiation. Melting curve analysis replaces post-PCR analysis involving nucleotide sequencing followed by comparison to a reference library of *Leishmania* strains \[[@CR48]\].

Kinetoplast DNA, which has often been used as a target due to its high sensitivity in the diagnosis of leishmaniasis, can only identify the parasite to the genus or subgenus level \[[@CR49]\]. The *cpb* gene, which has a relatively high copy number and showcases polymorphism between species, appear to give a more reliable species identification. It has been shown previously that the *cpb* gene could serve as an ideal target to differentiate between the different *Leishmania* species \[[@CR29], [@CR30], [@CR45], [@CR50]\] with a very high sensitivity (100 %) \[[@CR51]\]. However, in contrast to previous assays targeting the *cpb* gene which were only able to distinguish between *Leishmania* complexes \[[@CR52]\] or required multiple PCRs and post-PCR processing \[[@CR15], [@CR30], [@CR45]\], here we developed unique primers that can differentiate between the three OWCL species in a single rapid step.

Conclusion {#Sec16}
==========

In conclusion, we report a new highly sensitive FRET-based real-time PCR that can simultaneously identify the three species of Old World cutaneous leishmaniasis, *L. aethiopica*, *L. major* and *L. tropica,* from direct patient samples in a single step that could be used for rapid clinical diagnosis. However, as in any diagnostic procedure, the results of this assay need to be assessed in a routine diagnostic setting in light of the patient's history and symptoms.

CL

:   cutaneous leishmaniasis

*cpb*

:   cysteine proteinase B

FRET

:   Fluorescence Resonance Energy Transfer

OWCL

:   Old World CL

Tm

:   melting curve temperature
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